Your browser doesn't support javascript.
loading
Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.
Xu, Naiqing; Fang, Wenfeng; Mu, Libing; Tang, Yanna; Gao, Lei; Ren, Shengxiang; Cao, Dengfeng; Zhou, Lixin; Zhang, Aiqun; Liu, Deruo; Zhou, Caicun; Wong, Kwok-Kin; Yu, Lei; Zhang, Li; Chen, Liang.
Afiliación
  • Xu N; Graduate School of Peking Union Medical College, Beijing, China.
  • Fang W; National Institute of Biological Sciences, Beijing, China.
  • Mu L; Chinese Academy of Medical Sciences, Beijing, China.
  • Tang Y; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Gao L; Tsinghua University School of Medicine, Beijing, China.
  • Ren S; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Cao D; National Institute of Biological Sciences, Beijing, China.
  • Zhou L; Shanghai Pulmonary Hospital, Shanghai, China.
  • Zhang A; Cancer Hospital and Institute, Chinese Academy of Medical Sciences, Beijing, China.
  • Liu D; Peking University Cancer Hospital, Beijing, China.
  • Zhou C; General Hospital of People's Liberation Army, Beijing, China.
  • Wong KK; Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China.
  • Yu L; Shanghai Pulmonary Hospital, Shanghai, China.
  • Zhang L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chen L; Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Oncotarget ; 9(81): 35284, 2018 10 16.
Article en En | MEDLINE | ID: mdl-30443296

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: China